Company · CIK 0000921299 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
KYNTRA BIO, INC. · KYNB
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 6, 2026 FForm 4 → | Sep 9, 8:42 pm EDT | Thane WettigCEO, Director | 209 | $8.55 | $1,787 | 26,796 | — | |
| Sep 6, 2026 FForm 4 → | Sep 9, 8:41 pm EDT | David DeLuciaChief Financial Officer | 22 | $8.55 | $188 | 4,355 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.